Search results
Results From The WOW.Com Content Network
Cadila Pharmaceuticals has established a dedicated R&D facility, spread over 105,000 sq. ft. area at Dholka, Gujarat, India which is staffed by 300 scientists. [citation needed] The company has five IND dossiers filed with the USFDA for pulmonary tuberculosis, lung cancer, prostate cancer, bladder cancer and melanoma.
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, [3] is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. [4] [5] [6] The company ranked 100th in the Fortune India 500 list in 2020. [7]
The Pharmaceutical industry in Gujarat ranks number one in India with a 33% share in drug manufacturing and a 28% share in drug exports. The state has 130 USFDA certified drug manufacturing facilities.
ZyCoV-D is a DNA plasmid-based COVID-19 vaccine developed by Indian pharmaceutical company Cadila Healthcare, with support from the Biotechnology Industry Research Assistance Council. It is approved for emergency use in India.
Indravadan Ambalal Modi (18 February 1926 – 26 November 2012) [1] was an Indian pharmaceuticals industrialist who founded Cadila Pharmaceuticals in Ahmedabad.He is popularly known as the 'Medicine Man of India' for his contribution to the pharmaceutical industry of India post independence.
Cadila's stake in the company increased to over 70% in 2008, after the merger of Cadila's consumer goods business, which included sugar substitute brand Sugar Free and EverYuth range of skincare products, into Carnation. [11] The merged entity was then named as Zydus Wellness Limited in January 2009. [12] [13]
From Wikipedia, the free encyclopedia. Redirect page
Ramanbhai B. Patel (19 August 1925 – 19 September 2001) was an Indian chemist who founded the operation, along with school friend I A Modi, that eventually became the Ahmedabad-based pharmaceutical company Cadila Laboratories. [1] [2]